A disease-specific microarray analysis of BRCA1-mutant breast tumor tissue over sporadic tumors expressing wild-type BRCA1 found that the expression of ESR1, which is a coding gene for ER alpha, was significantly lower in BRCA1-mutant tumor tissue than in sporadic tumor tissues. The gene discussed is BRCA1; the disease is breast neoplasm.